Progress with HIV vaccines.
Biberfeld
G
G
Department of Immunology, National Bacteriological Laboratory, Stockholm, Sweden.
Emini
E A
EA
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D000818:Animals; D004195:Disease Models, Animal; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120 / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology; D015498:HIV-2 / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive; D008251:Macaca; D010446:Peptide Fragments / Q000276:immunology*; D015302:Simian Immunodeficiency Virus / Q000276:immunology; D015164:Vaccines, Inactivated
D016915:AIDS Vaccines; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments; D015164:Vaccines, Inactivated